Zimmer Biomet Holdings, Inc. (ZBH) Financial Statements
Zimmer Biomet Holdings, Inc. (ZBH) reported trailing twelve-month revenue of $8.5B (up 8.6% year on year) and net income of $806.6M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $1.2B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ZBHZimmer Biomet Holdings, Inc.Follow ZBH — free
—
Price chart with a free account
- Market cap
- 18.8B
- P/E TTM
- 23.9
- Dividend yield
- 1.0%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.10 | 4.22 | 7.93 | 7.98 | 6.13 | 6.83 | 6.94 | 7.39 | 7.68 | 8.23 | 8.51 | |
| Gross profit | 3.10 | 3.21 | 5.66 | 5.73 | 4.30 | 4.87 | 4.92 | 5.31 | 5.49 | 5.74 | 5.95 | |
| Research & development | 0.21 | 0.22 | 0.39 | 0.45 | 0.32 | 0.44 | 0.41 | 0.46 | 0.44 | 0.46 | 0.44 | |
| Operating income | 1.02 | 0.92 | 0.03 | 1.14 | 0.08 | 0.86 | 0.70 | 1.28 | 1.29 | 1.10 | 1.21 | |
| Pre-tax income | 1.00 | 0.86 | -0.27 | 0.91 | -0.11 | 0.50 | 0.40 | 1.07 | 1.04 | 0.83 | 0.93 | |
| Income tax | 0.28 | 0.26 | 0.11 | -0.23 | -0.10 | 0.05 | 0.11 | 0.04 | 0.13 | 0.13 | 0.13 | |
| Net income | 0.72 | 0.60 | -0.38 | 1.13 | -0.14 | 0.40 | 0.23 | 1.02 | 0.90 | 0.71 | 0.81 | |
| Diluted EPS ($) | 3.32 | 2.97 | -1.86 | 5.47 | -0.67 | 1.91 | 1.10 | 4.88 | 4.43 | 3.55 | 4.12 | |
| Diluted shares (bn) | 0.216 | 0.201 | 0.203 | 0.207 | 0.207 | 0.210 | 0.210 | 0.210 | 0.204 | 0.199 | — |
USD billions · SEC XBRL
Zimmer Biomet Holdings, Inc. — questions
- What is Zimmer Biomet Holdings, Inc.'s revenue?
- $8.5B over the twelve months to 2026-06-30, up 8.6% year on year, from its 10-Q and 10-K filings.
- What is Zimmer Biomet Holdings, Inc.'s net income?
- $806.6M over the twelve months to 2026-06-30.
- What is Zimmer Biomet Holdings, Inc.'s free cash flow?
- $1.2B over the twelve months to 2026-06-30.
- What are Zimmer Biomet Holdings, Inc.'s diluted earnings per share?
- $4.12 over the twelve months to 2026-06-30.
Every figure on this page comes from Zimmer Biomet Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.